Home DailyMed fd60f1b7-f970-44bd-8f94-4afa66c8a4fa National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2013-02-13
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:29:38 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065412-001 CEFACLOR CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-002 CEFACLOR CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-003 CEFACLOR CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-004 CEFACLOR CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 5bbf6a4d5a75…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.